Literature DB >> 11997098

The EF-hand calcium-binding protein calmyrin inhibits the transcriptional and DNA-binding activity of Pax3.

Andrew D Hollenbach1, Craig J McPherson, Irina Lagutina, Gerard Grosveld.   

Abstract

Pax3 is a member of the paired class homeodomain family of transcription factors and has been demonstrated to be an early marker in myogenic differentiation. To gain a better understanding of how protein-protein interactions regulate Pax3 transcriptional activity, we performed a yeast two-hybrid analysis to identify proteins that interact with Pax3. Screening of two cDNA libraries isolated nine independent clones that contained the complete encoding sequence of the EF-hand calcium-binding protein calmyrin. In this report, we demonstrate that calmyrin specifically interacts with Pax3 in vitro. In addition, we demonstrate that the interaction between Pax3 and calmyrin is mediated by the region of the Pax3 paired domain that is involved in making DNA contacts and the Pax3 octapeptide domain and its surrounding amino acid sequences. We also demonstrate that endogenous Pax3 and calmyrin are co-expressed in undifferentiated primary myoblasts and that calmyrin expression levels increase in the nucleus upon myogenic differentiation. Finally, we demonstrate that co-expression of calmyrin with Pax3 inhibits the transcriptional activity of Pax3 by inhibiting Pax3 from binding to its recognition DNA sequences. These results therefore suggest potential ways in which calcium, through its regulation of the EF-hand calcium-binding protein calmyrin, can alter the DNA-binding activity and subsequent transcriptional activity of Pax3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997098     DOI: 10.1016/s0167-4781(02)00230-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis.

Authors:  Patrick J Miller; Andrew D Hollenbach
Journal:  Biochim Biophys Acta       Date:  2007-07-13

2.  FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism.

Authors:  Aaron J Thomas; Carol A Erickson
Journal:  Development       Date:  2009-04-29       Impact factor: 6.868

3.  Identification of serine 205 as a site of phosphorylation on Pax3 in proliferating but not differentiating primary myoblasts.

Authors:  Patrick J Miller; Kevin N Dietz; Andrew D Hollenbach
Journal:  Protein Sci       Date:  2008-08-15       Impact factor: 6.725

4.  Comparative analysis of paired- and homeodomain-specific roles in PAX3-FKHR oncogenesis.

Authors:  Youbin Zhang; Joel Schwartz; Chiayeng Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-12-01

5.  Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1.

Authors:  Ana C Puhl; Jonathan W Bogart; Victoria A Haberman; Jacob E Larson; Andre S Godoy; Jacqueline L Norris-Drouin; Stephanie H Cholensky; Tina M Leisner; Stephen V Frye; Leslie V Parise; Albert A Bowers; Kenneth H Pearce
Journal:  ACS Chem Biol       Date:  2020-05-26       Impact factor: 5.100

6.  Calcium- and magnesium-dependent interactions between calcium- and integrin-binding protein and the integrin alphaIIb cytoplasmic domain.

Authors:  Aaron P Yamniuk; Hans J Vogel
Journal:  Protein Sci       Date:  2005-05-09       Impact factor: 6.725

7.  CIB1 and CaBP1 bind to the myo1c regulatory domain.

Authors:  Nanyun Tang; Tianming Lin; Jun Yang; J Kevin Foskett; E Michael Ostap
Journal:  J Muscle Res Cell Motil       Date:  2007-11-10       Impact factor: 2.698

Review 8.  Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.

Authors:  Jennifer D Kubic; Kacey P Young; Rebecca S Plummer; Anton E Ludvik; Deborah Lang
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

9.  Ozz-E3 ubiquitin ligase targets sarcomeric embryonic myosin heavy chain during muscle development.

Authors:  Yvan Campos; Xiaohui Qiu; Edmar Zanoteli; Simon Moshiach; Naja Vergani; Antonella Bongiovanni; A John Harris; Alessandra d'Azzo
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

10.  Tumor growth and angiogenesis is impaired in CIB1 knockout mice.

Authors:  Mohamed A Zayed; Weiping Yuan; Dan Chalothorn; James E Faber; Leslie V Parise
Journal:  J Angiogenes Res       Date:  2010-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.